Apeloa Pharmaceutical's low P/E ratio is justified by expect...

Apeloa Pharmaceutical's low P/E ratio is justified by expected slower growth. Shareholders accept this as they anticipate future earnings may not provide pleasant surprises, potentially limiting a strong share price rise.